Drug Trial Radar · NCT00075699
Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma
Last checked: Nov 19, 2026Latest source record: Aug 7, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
840
Planned (sponsor's estimate)
Start
Sep 2003
Primary completion
Not stated
Sponsor
- Lead sponsor
- Medical Research CouncilGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Jan 13, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Active symptom control may decrease chest pain, breathlessness, sweating, and general discomfort in patients with malignant pleural mesothelioma. It is not yet known if active symptom control is more effective with or without chemotherapy. PURPOSE: This randomized phase III trial is studying active symptom control and chemotherapy to see how well they work compared to active symptom control alone in treating patients with malignant pleural mesothelioma.
Conditions
- Malignant Mesothelioma
Interventions
cisplatinDrug
mitomycin CDrug
vincristine sulfateDrug
vinorelbine tartrateDrug
pain therapyProcedure
psychosocial assessment and careProcedure
quality-of-life assessmentProcedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall survival
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Leeds General Infirmary at Leeds Teaching Hospital NHS Trust
Leeds, England, United Kingdom
Saint Bartholomew's Hospital
London, England, United Kingdom
Royal Marsden NHS Foundation Trust - Surrey
Sutton, England, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.